11/03/2025 | Press release | Distributed by Public on 11/03/2025 20:40
| 
           
            FORM 4
           
          
  | 
        
          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940  | 
        
          
  | 
      
          
  | 
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
          
  | 
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
| 
          1. Title of Derivative Security (Instr. 3)  | 
        2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 
          4. Transaction Code (Instr. 8)  | 
        
          5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)  | 
        
          6. Date Exercisable and Expiration Date (Month/Day/Year)  | 
        
          7. Title and Amount of Underlying Securities (Instr. 3 and 4)  | 
        
          8. Price of Derivative Security (Instr. 5)  | 
        
          9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)  | 
        
          10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)  | 
        
          11. Nature of Indirect Beneficial Ownership (Instr. 4)  | 
      ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Stock Option (right to buy) | $13.01 | 11/03/2025 | M | 2,084 | (5) | 01/10/2029 | Common Stock | 2,084 | $ 0 | 0 | D | ||||
| Stock Option (right to buy) | $20.27 | 11/03/2025 | M | 3,595 | (5) | 04/11/2029 | Common Stock | 3,595 | $ 0 | 0 | D | ||||
| Stock Option (right to buy) | $119.75 | 11/03/2025 | M | 150,000 | (6) | 01/21/2031 | Common Stock | 150,000 | $ 0 | 0 | D | ||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
| 
          Chapman Steven Leonard C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN, TX 78753  | 
        X | CEO AND PRESIDENT | ||
| /s/ Vincent Fontanilla, Attorney-in-Fact | 11/03/2025 | |
| **Signature of Reporting Person | Date | 
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). | 
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | 
| (1) | The sale of shares on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024. The sale of 150,000 of these shares was governed by the initial plan and not altered by the subsequently amendment. | 
| (2) | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.28 to $198.27 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | 
| (3) | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.44 to $199.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | 
| (4) | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.51 to $200.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | 
| (5) | The option shares are fully exercisable. | 
| (6) | On January 22, 2021, the Reporting Person was granted performance-based options which vest in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. The performance thresholds were certified on June 28, 2024, March 28, 2025 and September 28, 2025, resulting in the performance-based option being fully vested as of the last performance threshold date. |